Market Cap 767.09M
Revenue (ttm) 864.70M
Net Income (ttm) 16.63M
EPS (ttm) N/A
PE Ratio 19.54
Forward PE 13.93
Profit Margin 1.92%
Debt to Equity Ratio -2.77
Volume 232,500
Avg Vol 560,930
Day's Range N/A - N/A
Shares Out 67.94M
Stochastic %K 97%
Beta 1.20
Analysts Strong Sell
Price Target $15.43

Company Profile

MediaAlpha, Inc., through its subsidiaries, operates an insurance customer acquisition platform in the United States. Its technology platform offers end customer acquisition for insurance carriers, distributors, and other clients in a range of verticals, including property and casualty insurance, health insurance, and life insurance. The company was founded in 2014 and is headquartered in Los Angeles, California.

Industry: Internet Content & Information
Sector: Communication Services
Phone: 213 316 6256
Address:
700 South Flower Street, Suite 640, Los Angeles, United States
ZacksResearch
ZacksResearch Oct. 15 at 1:42 PM
Tech rebound incoming? Here are 5 names set to shine this quarter 🌟 $APP, $SKIL, $AYI, $BYRN and $MAX are highlighted as top buys as the Technology Services industry shows strong momentum heading into Q4. Find out what makes these stocks stand out 👉 https://www.zacks.com/stock/news/2768986/5-technology-services-stocks-to-buy-for-stellar-returns-in-q4?cid=sm-stocktwits-2-2768986-teaser-16112&ADID=SYND_STOCKTWITS_TWEET_2_2768986_TEASER_16112
0 · Reply
JarvisFlow
JarvisFlow Oct. 15 at 11:06 AM
Goldman Sachs updates rating for MediaAlpha ( $MAX ) to Neutral, target set at 14.5 → 12.
0 · Reply
Investogainerresearch
Investogainerresearch Oct. 6 at 5:58 PM
$MAXHEALTH.NSE बहतर सेहत, बेहतरीन निवेश—MAXHEALTH शेयर के साथ सुरक्षित भविष्य की ओर बढ़ें। Technical View — Daily Chart $MAX Healthcare formed a wide-range bullish reversal candle today after opening at ₹1,107.90, making an intraday low of ₹1,101.80 and a high of ₹1,148.10 before closing at ₹1,143.20, which signals strong intraday buying and short-covering. $PRICE is now holding above the 14 day EMA and the ₹1,135 horizontal support, with RSI rebounding from sub 50 toward the mid 50s and daily MACD histogram flattening (still negative), suggesting a short term mean reversion attempt rather than a confirmed trend reversal. Key intraday/near term levels: support ₹1,135 (14 day EMA) and ₹1,120 (stopwatch support); immediate resistance ₹1,190–₹1,200 and higher resistance cluster near the 50 DMA around ₹1,240–1,260. Volume/structure note: Today’s $RANGE expansion on higher volumes relative to the prior down days supports the probability of a follow through; look for sustained volume above the 10 day average to validate continuation. Trade plan (actionable) Short term trading (speculative): Buy on dips ₹1,135–1,140; Stop loss ₹1,120; Targets ₹1,190 (first) and ₹1,200 (stretch). Scale out 50% at first target. Intraday setup: Long above intraday high ₹1,148 on momentum with tight trailing stop below the 14 EMA. Positional/Investors: Prefer staggered accumulation (SIP style) or wait for consolidation above ₹1,200 to reduce valuation risk. Short / Medium / Long term technical bias Short term (days–weeks): Constructive if ₹1,135 holds; expect 1,190–1,200 in a follow through scenario. Medium term (weeks–months): Neutral to cautious; stock still below longer moving averages, needs a higher high and higher low confirmation. Long term (12+ months): Positive business case but technical confirmation required — watch monthly close relative to the 50 and 100 month smoothing for structural turn. Upcoming News / Events & Likely Impact •CGHS Rate Revision: Government revised CGHS package rates across ~2,000 procedures (effective mid October window), boosting realization outlook for hospital chains handling CGHS cases; market reacted positively to this sectoral tailwind and it is a near term revenue/margin catalyst. •Earnings / Board dates: Monitor next quarterly updates and management commentary on occupancy, ARPOB, and guidance — any upside surprise can trigger strong moves; a miss may cause sharp re-rating because of current high multiples. •Other events to watch: policy updates on insurance reimbursements, NABH/NABL accreditations, and major tie-ups with insurers or govt schemes which can affect volumes and collections. Disclosure & Disclaimer This note is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Market and stock prices may be volatile; investors should perform their own due diligence or consult a registered financial adviser before taking any position. Past performance is not an indicator of future returns. Data and news references are taken from public sources and brokerage reports (news articles and company filings) available as of the date of this note. No position in Max Healthcare is held at the time of writing.
0 · Reply
StormPivot
StormPivot Oct. 5 at 11:13 AM
$MAX Technology services growth. Testing resistance level. Volume confirmation needed. Sector momentum building.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 9 at 5:58 AM
$MAX Really good write-up that perfectly summarizes MAX's present situation. So if you want to bring your MAX knowledge up to date or just discover MAX, this is required reading. https://beyondspx.com/quote/MAX/analysis/mediaalpha-s-resurgence-capitalizing-on-digital-insurance-shifts-nyse-max
0 · Reply
JarvisFlow
JarvisFlow Sep. 5 at 12:00 PM
Keefe, Bruyette & Woods has adjusted their stance on MediaAlpha ( $MAX ), setting the rating to Outperform with a target price of 17 → 18.
0 · Reply
GoParabolic
GoParabolic Sep. 5 at 4:12 AM
$MAX should be shorted now. Some people already knew the stock repurchase at 10.17 2 days ago. If you do not want to be a bag holder, dump it.
1 · Reply
GoParabolic
GoParabolic Sep. 5 at 4:10 AM
$MAX some people knew that stock purchase would be announced in 2 days and then kept loading. When you buy, they will sell and make you a bag holder. What a ethic....
0 · Reply
DrabCrab5
DrabCrab5 Sep. 4 at 10:39 PM
$MAX love the opportunistic buyback from management. Shares repurchased at a discount, repurchase is accretive, and removes overhang from shareholder selling down over time
0 · Reply
matmasr
matmasr Sep. 4 at 6:38 PM
$MAX time for me to take a short position. Overbought. But could be wrong of course. Shorted at 11.80
1 · Reply
Latest News on MAX
MediaAlpha Announces $32.9 Million Private Stock Repurchase

Sep 4, 2025, 4:10 PM EDT - 7 weeks ago

MediaAlpha Announces $32.9 Million Private Stock Repurchase


MediaAlpha, Inc. (MAX) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:07 AM EDT - 2 months ago

MediaAlpha, Inc. (MAX) Q2 2025 Earnings Call Transcript


MediaAlpha Announces Second Quarter 2025 Financial Results

Aug 6, 2025, 4:08 PM EDT - 2 months ago

MediaAlpha Announces Second Quarter 2025 Financial Results


MediaAlpha Reaches Settlement with FTC

Aug 6, 2025, 4:05 PM EDT - 2 months ago

MediaAlpha Reaches Settlement with FTC


MediaAlpha Appoints Amy Yeh as Chief Technology Officer

Jun 30, 2025, 9:00 AM EDT - 4 months ago

MediaAlpha Appoints Amy Yeh as Chief Technology Officer


MediaAlpha, Inc. (MAX) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 7:45 PM EDT - 6 months ago

MediaAlpha, Inc. (MAX) Q1 2025 Earnings Call Transcript


MediaAlpha Announces First Quarter 2025 Financial Results

Apr 30, 2025, 4:05 PM EDT - 6 months ago

MediaAlpha Announces First Quarter 2025 Financial Results


MediaAlpha Adds Bradley Hunt to Board of Directors

Mar 31, 2025, 5:46 PM EDT - 7 months ago

MediaAlpha Adds Bradley Hunt to Board of Directors


MediaAlpha Names Keith Cramer as Chief Revenue Officer

Mar 25, 2025, 9:00 AM EDT - 7 months ago

MediaAlpha Names Keith Cramer as Chief Revenue Officer


MediaAlpha, Inc. (MAX) Q4 2024 Earnings Call Transcript

Feb 24, 2025, 6:18 PM EST - 8 months ago

MediaAlpha, Inc. (MAX) Q4 2024 Earnings Call Transcript


ZacksResearch
ZacksResearch Oct. 15 at 1:42 PM
Tech rebound incoming? Here are 5 names set to shine this quarter 🌟 $APP, $SKIL, $AYI, $BYRN and $MAX are highlighted as top buys as the Technology Services industry shows strong momentum heading into Q4. Find out what makes these stocks stand out 👉 https://www.zacks.com/stock/news/2768986/5-technology-services-stocks-to-buy-for-stellar-returns-in-q4?cid=sm-stocktwits-2-2768986-teaser-16112&ADID=SYND_STOCKTWITS_TWEET_2_2768986_TEASER_16112
0 · Reply
JarvisFlow
JarvisFlow Oct. 15 at 11:06 AM
Goldman Sachs updates rating for MediaAlpha ( $MAX ) to Neutral, target set at 14.5 → 12.
0 · Reply
Investogainerresearch
Investogainerresearch Oct. 6 at 5:58 PM
$MAXHEALTH.NSE बहतर सेहत, बेहतरीन निवेश—MAXHEALTH शेयर के साथ सुरक्षित भविष्य की ओर बढ़ें। Technical View — Daily Chart $MAX Healthcare formed a wide-range bullish reversal candle today after opening at ₹1,107.90, making an intraday low of ₹1,101.80 and a high of ₹1,148.10 before closing at ₹1,143.20, which signals strong intraday buying and short-covering. $PRICE is now holding above the 14 day EMA and the ₹1,135 horizontal support, with RSI rebounding from sub 50 toward the mid 50s and daily MACD histogram flattening (still negative), suggesting a short term mean reversion attempt rather than a confirmed trend reversal. Key intraday/near term levels: support ₹1,135 (14 day EMA) and ₹1,120 (stopwatch support); immediate resistance ₹1,190–₹1,200 and higher resistance cluster near the 50 DMA around ₹1,240–1,260. Volume/structure note: Today’s $RANGE expansion on higher volumes relative to the prior down days supports the probability of a follow through; look for sustained volume above the 10 day average to validate continuation. Trade plan (actionable) Short term trading (speculative): Buy on dips ₹1,135–1,140; Stop loss ₹1,120; Targets ₹1,190 (first) and ₹1,200 (stretch). Scale out 50% at first target. Intraday setup: Long above intraday high ₹1,148 on momentum with tight trailing stop below the 14 EMA. Positional/Investors: Prefer staggered accumulation (SIP style) or wait for consolidation above ₹1,200 to reduce valuation risk. Short / Medium / Long term technical bias Short term (days–weeks): Constructive if ₹1,135 holds; expect 1,190–1,200 in a follow through scenario. Medium term (weeks–months): Neutral to cautious; stock still below longer moving averages, needs a higher high and higher low confirmation. Long term (12+ months): Positive business case but technical confirmation required — watch monthly close relative to the 50 and 100 month smoothing for structural turn. Upcoming News / Events & Likely Impact •CGHS Rate Revision: Government revised CGHS package rates across ~2,000 procedures (effective mid October window), boosting realization outlook for hospital chains handling CGHS cases; market reacted positively to this sectoral tailwind and it is a near term revenue/margin catalyst. •Earnings / Board dates: Monitor next quarterly updates and management commentary on occupancy, ARPOB, and guidance — any upside surprise can trigger strong moves; a miss may cause sharp re-rating because of current high multiples. •Other events to watch: policy updates on insurance reimbursements, NABH/NABL accreditations, and major tie-ups with insurers or govt schemes which can affect volumes and collections. Disclosure & Disclaimer This note is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Market and stock prices may be volatile; investors should perform their own due diligence or consult a registered financial adviser before taking any position. Past performance is not an indicator of future returns. Data and news references are taken from public sources and brokerage reports (news articles and company filings) available as of the date of this note. No position in Max Healthcare is held at the time of writing.
0 · Reply
StormPivot
StormPivot Oct. 5 at 11:13 AM
$MAX Technology services growth. Testing resistance level. Volume confirmation needed. Sector momentum building.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 9 at 5:58 AM
$MAX Really good write-up that perfectly summarizes MAX's present situation. So if you want to bring your MAX knowledge up to date or just discover MAX, this is required reading. https://beyondspx.com/quote/MAX/analysis/mediaalpha-s-resurgence-capitalizing-on-digital-insurance-shifts-nyse-max
0 · Reply
JarvisFlow
JarvisFlow Sep. 5 at 12:00 PM
Keefe, Bruyette & Woods has adjusted their stance on MediaAlpha ( $MAX ), setting the rating to Outperform with a target price of 17 → 18.
0 · Reply
GoParabolic
GoParabolic Sep. 5 at 4:12 AM
$MAX should be shorted now. Some people already knew the stock repurchase at 10.17 2 days ago. If you do not want to be a bag holder, dump it.
1 · Reply
GoParabolic
GoParabolic Sep. 5 at 4:10 AM
$MAX some people knew that stock purchase would be announced in 2 days and then kept loading. When you buy, they will sell and make you a bag holder. What a ethic....
0 · Reply
DrabCrab5
DrabCrab5 Sep. 4 at 10:39 PM
$MAX love the opportunistic buyback from management. Shares repurchased at a discount, repurchase is accretive, and removes overhang from shareholder selling down over time
0 · Reply
matmasr
matmasr Sep. 4 at 6:38 PM
$MAX time for me to take a short position. Overbought. But could be wrong of course. Shorted at 11.80
1 · Reply
FelipeLuis
FelipeLuis Aug. 11 at 5:58 PM
$MAX Why is that big drop today? Anyone knows anything?
1 · Reply
DrabCrab5
DrabCrab5 Aug. 11 at 3:20 PM
$MAX some kind of sector news here? $MAX $QNST $EVER
0 · Reply
Biggame417
Biggame417 Aug. 7 at 3:27 AM
$MAX nice jump...
0 · Reply
GoParabolic
GoParabolic Jul. 29 at 12:23 PM
$MAX is getting good ratings. $TSLA $AMZN $MSFT $NVDA
0 · Reply
Biggame417
Biggame417 Jul. 11 at 3:36 AM
$MAX lovn it..
0 · Reply
GoParabolic
GoParabolic Jul. 9 at 8:25 PM
$MAX is updated. $TSLA $BTC.X $NVDA $META
0 · Reply
GoParabolic
GoParabolic Jul. 9 at 8:01 PM
$MAX is undervalued and will be thriving... $NVDA $AMZN $MSFT $TSLA
0 · Reply
Estimize
Estimize Jul. 2 at 9:00 PM
Wall St is expecting 0.16 EPS for $MAX Q2 [Reporting 07/30 AMC] http://www.estimize.com/intro/max?chart=historical&metric_name=eps&utm_cont
0 · Reply
kej32
kej32 Jun. 4 at 9:01 PM
$MAX Slowly building up. Room is quiet for now. Soon enough…soon enough!!!
0 · Reply
50bps
50bps May. 15 at 6:56 PM
$MAX 👀
1 · Reply
FelipeLuis
FelipeLuis May. 8 at 4:05 PM
$MAX Marget is green but this one is Red. $MAX you are the real beauty of the market 😡
0 · Reply